Lea Westman and Piers Blewett Share IP Strategies at MD&M Event

 

When executives and inventors develop medical device technology, there are a host of intellectual property issues to consider. Schwegman attorneys Lea Westman and Piers Blewett provided an overview of these key IP issues when they spoke at the BIOMEDevice convention in San Jose, California. Their December 4 presentation, “Medical Device IP Strategies for Executives and Inventors,” covered important topics that can arise when medical device technology is developed.

Lea and Piers’ talk included issues such as IP ownership, patentability, patent portfolio management, and freedom-to-operate. They also spoke about IP due diligence during fundraising or merger/acquisition, and models for valuing intellectual property.

Piers explains, “It was great to discuss our strategies in real-time with attendees. IP is clearly a topic of great interest to small and large companies seeking to gain a key advantage. By the end of our talk there was standing room only.”    

Lea describes, “There were lots of questions, and lots of engagement from the audience. We provided an overview of patents generally, including discussion of ‘what is a patent,’ and what strategies to keep in mind if you want to file a patent.”

BIOMEDevice, an MD&M event, took place December 4 and 5 at the San Jose Convention Center. The focus areas of the medical design and manufacturing event included digital health; in vitro diagnostics; and interventional, surgical, and minimally invasive devices.

In October 2019, Lea Westman and Doug Portnow spoke at MD&M Minneapolis. Schwegman attorneys will also be presenting at MD&M West in Anaheim, California on February 13.

To learn more about IP issues for medical device companies, listen to the SLW Institute’s webinar, “IP for Medical Device Companies: What to Consider During Fundraising … Or Exit.” The November 7 webinar is now available on demand.

  Back to All News